tiprankstipranks
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
US Market

REPRO-MED Systems (KRMD) Stock Statistics & Valuation Metrics

295 Followers

Total Valuation

REPRO-MED Systems has a market cap or net worth of $194.29M. The enterprise value is $188.92M.
Market Cap$194.29M
Enterprise Value$188.92M

Share Statistics

REPRO-MED Systems has 46,370,434 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,370,434
Owned by Insiders14.62%
Owned by Institutions24.28%

Financial Efficiency

REPRO-MED Systems’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is -14.47%.
Return on Equity (ROE)-0.15
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-14.47%
Return on Capital Employed (ROCE)-0.15
Revenue Per Employee514.09K
Profits Per Employee-32.97K
Employee Count80
Asset Turnover1.46
Inventory Turnover4.44

Valuation Ratios

The current PE Ratio of REPRO-MED Systems is ―. REPRO-MED Systems’s PEG ratio is 1.81.
PE Ratio
PS Ratio6.52
PB Ratio15.74
Price to Fair Value15.74
Price to FCF-570.81
Price to Operating Cash Flow423.51
PEG Ratio1.81

Income Statement

In the last 12 months, REPRO-MED Systems had revenue of 41.13M and earned -2.64M in profits. Earnings per share was -0.06.
Revenue41.13M
Gross Profit25.60M
Operating Income-2.97M
Pretax Income-2.62M
Net Income-2.64M
EBITDA-2.16M
Earnings Per Share (EPS)-0.06

Cash Flow

In the last 12 months, operating cash flow was 462.40K and capital expenditures -932.52K, giving a free cash flow of -470.12K billion.
Operating Cash Flow462.40K
Free Cash Flow-470.12K
Free Cash Flow per Share-0.01

Dividends & Yields

REPRO-MED Systems pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.18
52-Week Price Change83.77%
50-Day Moving Average4.66
200-Day Moving Average4.48
Relative Strength Index (RSI)37.30
Average Volume (3m)198.68K

Important Dates

REPRO-MED Systems upcoming earnings date is May 6, 2026, After Close (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateMay 6, 2026
Ex-Dividend Date

Financial Position

REPRO-MED Systems as a current ratio of 2.44, with Debt / Equity ratio of 20.51%
Current Ratio2.44
Quick Ratio1.99
Debt to Market Cap0.01
Net Debt to EBITDA2.49
Interest Coverage Ratio0.00

Taxes

In the past 12 months, REPRO-MED Systems has paid 21.89K in taxes.
Income Tax21.89K
Effective Tax Rate>-0.01

Enterprise Valuation

REPRO-MED Systems EV to EBITDA ratio is -121.64, with an EV/FCF ratio of -559.38.
EV to Sales6.39
EV to EBITDA-121.64
EV to Free Cash Flow-559.38
EV to Operating Cash Flow568.70

Balance Sheet

REPRO-MED Systems has $8.87M in cash and marketable securities with $3.50M in debt, giving a net cash position of $5.38M billion.
Cash & Marketable Securities$8.87M
Total Debt$3.50M
Net Cash$5.38M
Net Cash Per Share$0.12
Tangible Book Value Per Share$0.35

Margins

Gross margin is 60.28%, with operating margin of -7.23%, and net profit margin of -6.41%.
Gross Margin60.28%
Operating Margin-7.23%
Pretax Margin-6.36%
Net Profit Margin-6.41%
EBITDA Margin-5.26%
EBIT Margin-7.23%

Analyst Forecast

The average price target for REPRO-MED Systems is $6.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.75
Price Target Upside61.10% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast22.12%
EPS Growth Forecast69.19%

Scores

Smart Score6
AI Score